Company information:

UCB Bulgaria is integral part of UCB group of companies: a global biopharmaceutical company with the ambition to transform the lives of people living with severe diseases, allowing them to live the best life that they can – as free as possible from the challenges and uncertainty of disease. That commitment comes to life in our research and development activities across neurology, immunology, and other areas where our expertise, innovation and ambition align with unmet needs. 

UCB’s business is strong and ranked 3rd among top Belgium companies by market capitalization as of December 2022*, with total revenue reaching €5.5 billion in 2022. This success is powered by the approximately 8,700 people – from our headquarters in Belgium and across nearly 40 countries worldwide. 

* Source: EURONEXT

Company details

Year of establishment: 2001
Number of employees: 9
Key investments since establishment in Bulgaria: >1 million Bulgarian patients’ lives covered with UCB solutions since its presence in the country and ~70 thousand annualized average treated patients in 2022**. >3.3€ million local R&D and >1€ million investment in healthcare professionals & patient organizations’ education and support for the 2017-2021 period#. UCB products for >15€ million released on the local market in 2022**. ** Source: IQVIA # Source: http://www.transparencybg.org/
Phone: +359 (2) 962 30 49
Email: Office.Bulgaria@ucb.com
Address: Sofia 1407, 2B Srebarna Street, Floor 9, Office 8B

Share this page